Learn About Scleritis

What is the definition of Scleritis?

The sclera is the white outer wall of the eye. Scleritis is present when this area becomes swollen or inflamed.

What are the alternative names for Scleritis?

Inflammation - sclera

What are the causes of Scleritis?

Scleritis is often linked to autoimmune diseases. These diseases occur when the body's immune system attacks and destroys healthy body tissue by mistake. Rheumatoid arthritis and systemic lupus erythematosus are examples of autoimmune diseases that can be associated with scleritis. Sometimes the cause is unknown.

Scleritis occurs most often in people between the ages of 30 and 60. It is rare in children.

What are the symptoms of Scleritis?

Symptoms of scleritis include:

  • Blurred vision
  • Eye pain and tenderness -- severe
  • Red patches on the normally white part of the eye
  • Sensitivity to light -- can be painful
  • Tearing of the eye

A rare form of this disease causes no eye pain or redness.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Scleritis?

Treatments for scleritis may include:

  • Corticosteroid eye drops to help reduce the inflammation
  • Corticosteroid pills
  • Newer, nonsteroid anti-inflammatory drugs (NSAIDs) in some cases
  • Certain anticancer drugs (immune-suppressants) to help reduce the inflammation in severe cases

If scleritis is caused by an underlying disease, treatment of that disease may be needed.

Who are the top Scleritis Local Doctors?
James T. Rosenbaum
Elite in Scleritis
Rheumatology | Ophthalmology
Elite in Scleritis
Rheumatology | Ophthalmology

Legacy Good Samaritan Hospital And Medical Center

1040 Nw 22nd Ave, Suite 168, 
Portland, OR 
Languages Spoken:
English
Accepting New Patients

James Rosenbaum is a Rheumatologist and an Ophthalmologist in Portland, Oregon. Dr. Rosenbaum is rated as an Elite provider by MediFind in the treatment of Scleritis. His top areas of expertise are Uveitis, Scleritis, Sarcoidosis, Vitrectomy, and Trabeculectomy. Dr. Rosenbaum is currently accepting new patients.

Careen Lowder
Elite in Scleritis
Ophthalmology
Elite in Scleritis
Ophthalmology

Cleveland Clinic Main Campus

2022 East 105th Street, 
Cleveland, OH 
Experience:
55+ years
Languages Spoken:
English, Mandarin, Portuguese

Careen Lowder is an Ophthalmologist in Cleveland, Ohio. Dr. Lowder has been practicing medicine for over 55 years and is rated as an Elite provider by MediFind in the treatment of Scleritis. Her top areas of expertise are Uveitis, Scleritis, Birdshot Chorioretinopathy, Trabeculectomy, and Vitrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Scleritis
Elite in Scleritis

Cleveland Clinic

9500 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English
Accepting New Patients

Sunil Srivastava is an Ophthalmologist in Cleveland, Ohio. Dr. Srivastava is rated as an Elite provider by MediFind in the treatment of Scleritis. His top areas of expertise are Uveitis, Scleritis, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Srivastava is currently accepting new patients.

What is the outlook (prognosis) for Scleritis?

In most cases, scleritis goes away with treatment. But it may come back.

If there is a disorder causing scleritis, it may be serious. However, it may not be discovered the first time you have the problem. The outcome will depend on the specific underlying disorder.

What are the possible complications of Scleritis?

Complications may include:

  • Return of scleritis
  • Side effects of long-term corticosteroid therapy
  • Perforation of the eyeball, leading to vision loss if the condition is left untreated
When should I contact a medical professional for Scleritis?

Contact your provider or ophthalmologist if you have symptoms of scleritis.

How do I prevent Scleritis?

Most cases cannot be prevented.

People with autoimmune diseases, may need to have regular check-ups with an ophthalmologist familiar with the condition.

What are the latest Scleritis Clinical Trials?
Development of an International Multicenter Registry of Patients With Monogenic and Polygenic Autoinflammatory Diseases Aimed at Clinical and Therapeutical Data Collection and Analysis

Summary: Autoinflammatory diseases (AID) are clinical entities characterized by recurrent inflammatory attacks in absence of infection, neoplasm or deregulation of the adaptive immune system. Among them, hereditary periodic syndromes, also known as monogenic AID, represent the prototype of this disease group, caused by mutations in genes involved in the regulation of innate immunity, inflammation and cell ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open Label, Multi-centered, Randomized Phase 2 Study to Evaluate the Safety, Tolerability and Bioactivity of Subcutaneous ACTH GeL in PAtients With Scleritis: The ATLAS Study

Summary: ATLAS study is a clinical trial to evaluate the potential role of subcutaneous adrenocorticotropic hormone (ACTH) gel in the management of non-infectious scleritis. Specifically, the ATLAS Study aims to evaluate the safety, tolerability and effect of 2 different dose regimens of ACTH gel administered by subcutaneous (SC) injection in patients with scleritis, over a period of 12 months. Scleritis i...

Who are the sources who wrote this article ?

Published Date: July 09, 2024
Published By: Audrey Tai, DO, MS, Athena Eye Care, Mission Viejo, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Barry RJ, Denniston AK, Rhodes B, et al. Rheumatic disease. In: Sadda SVR, Sarraf D, Freund KB, et al, eds. Ryan's Retina. 7th ed. Philadelphia, PA: Elsevier; 2023:chap 81.

Cioffi GA, Liebmann JM. Diseases of the visual system. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 391.

Patel SS, Zaguia F, Goldstein DA. Episcleritis and scleritis. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 4.11.